Abstract
The requirement of vitamins for growth and development, as well as their central role in carcinogen metabolism, has called the attention of many investigators toward their potential involvement in tumor induction and growth. Vitamins A, C, and E have been most associated with cancer (Committee on Diet, Nutrition, and Cancer, 1982), and the consumption of foods rich in these nutrients has been encouraged in public information brochures by major cancer organizations (e.g., the American Institute for Cancer Research and the American Cancer Society), and most recently, The Surgeon General’s Report on Nutrition and Health (Nutrition Policy Board, 1988) and Diet and Health (National Research Council, 1989).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Abe, E., Miyaura, C., Sakagami, H., Takeda, M., Konno, K., Yamazaki, T., Yoshiki, S., and Suda, T., 1981, Differentiation of mouse myeloid leukemia cells induced by 1-alpha, 25-dihydroxyvitamin D3, Proc. Natl. Acad. Sci. USA 78: 4990–4994.
Ahmann, F. R., and Durie, B. G. M., 1984, Acute myelogenous leukemia modulation by B12 deficiency: A case with bone marrow blast cell assay corroboration, Br. J. Haematol. 58: 91–94.
Ajdokiewicz, A., and Pollit, N., 1976, Letter to the editor: Liver carcinoma and pyroxidine deficiency, Am. J. Clin. Nutr. 29 (8): 813.
Aksoy, M., Basu, T. K., Brient, J., and Dickerson, J. W. T., 1980, Thiamin status of patients treated with drug combinations containing 5-flurouracil, Eur. J. Cancer 16: 1041–1045.
Alberts, D., Peng, Y., and Moon, T., 1978, Alpha -tocopherol pretreatment increases adriamycin bone marrow toxicity, Biomedicine 29: 189–191.
Alvi, N. K., Ahmad, S., and Hadi, S. M., 1984, Effect of riboflavin and light on the secondary structure of DNA, Chem. Biol. Interact. 48: 367–376.
Arvanitakis, C., Holmes, F. H., and Hearne, E., III, 1979, A possible association of pernicious anemia with neoplasia, Oncology 36: 127–129.
Atukorala, S., Basu, T., Dickerson, J., Donaldson, D., and Sakula, A., 1979, Vitamin A, zinc and lung cancer, Br. J. Cancer 40: 927–931.
Baker, H., Frank, O., Chen, T., Feingold, S., DeAngelis, B., and Baker, E. R., 1981, Elevated vitamin levels in colon adenocarcinoma as compared with metastatic liver adenocarcinoma from colon primary and normal adjacent tissue, Cancer 47: 2883–2886.
Band, P., Besner, J., Leclaire, R., Girard, C., Diorio, G., Deschamps, M., Gelinas, G., and Larochelle, D., 1982, Phase II study of 13-cis-retinoic acid toxicity, Cancer Treat. Rep. 66: 1759–1761.
Barra, R., Randolph, V., Sumas, M. E., Lanighan, K., and Lea, M. A., 1982, Effects of nicotinamide, isonicotinamide and bleomycin on DNA synthesis and repair in rat heptaocytes and hepatoma cells, J. Natl. Cancer Inst. 69: 1353–1357.
Basu, T. K., and Dickerson, J. W. T., 1976, The thiamin status of early cancer patients with particular reference to those with breast and bronchial carcinomas, Oncology 33: 250–252.
Basu, T. K., Dickerson, J. W. T., Raven, R. W., and Williams, D C, 1974, The thiamin status of patients with cancer as determined by the red cell transketolase activity, Int. J. Vit. Nutr. Res. 44: 53–58.
Basu, T., Donaldson, D., Jenner, M., Williams, D., and Sakula, A., 1976, Plasma vitamin A in patients with bronchial carcinoma, Br. J. Cancer 33: 119–121.
Baugh, C. M., Krumdieck, C. L., and Nair, M. S., 1973, Polyglutamyl metabolites of methotrexate, Biochem. Biophys. Res. Commun. 52: 27–34.
Beard, M. F., Pitney, W. R., and Sanneman, E. H., 1954, Serum concentration of vitamin B12 in patients suffering from leukemia, Blood 9: 789–794.
Bell, E., 1980, The excretion of a vitamin B6 metabolite and the probability of recurrence of early breast cancer, Eur. J. Cancer 16: 297–298.
Bellog, W., and Ott, F., 1971, Therapy of actinic keratoses and basal cell carcinomas with local application of vitamin A acid, Cancer Chemother. Rep. 55: 59–60.
Berger, N. A., Catino, D. M., and Vietti, T. J., 1982, Synergistic antileukemic effect of 6-aminonicotinamide and 1,3-bis(2-chloroethyl)-1-nitrosourea on L1210 cells in vitro, Cancer Res. 42: 4382–4386.
Bertram, J. S., Kolonel, L. N., and Meyskens, F. L., Jr., 1987, Rationale and strategies for chemoprevention of cancer in humans, Cancer Res. 47: 3012–3031.
Bichler, A., Fuchs, D., Hausen, A., Hetzel, H., Konig, K., and Wachter, H., 1982, Urinary neopterine excretion in patients with genital cancer, Clin. Biochem. 15: 38–40.
Bidlack, W. R., Brown, R. C., and Mohan, C., 1986, Nutritional parameters that alter hepatic drug metabolism, conjugation, and toxicity, Fed. Proc. 45: 142–148.
Birt, D. F., 1986, Update on the effects of vitamins A, C, and E and selenium on carcinogenesis, Proc. Soc. Exp. Biol. Med. 183: 311–320.
Bjelke, E., 1975, Dietary vitamin A and lung cancer, Int. J. Cancer 15: 561–565.
Blakeslee, J. R., Yamamoto, N., and Hinuma, Y., 1985, Human T-cell leukemia virus I induction by 5-iodo-2’deoxyuridine and N-methyl-N’-nitro-N-nitrosoguanidine: Inhibition by retinoids, L-ascorbic acid, and DLalpha-tocopherol, Cancer Res. 45: 3471–3476.
Bleyer, W. A., 1978, The clinical pharmacology of methotrexate, Cancer 41: 36–51.
Block, G., and Sorenson, A., 1987, Vitamin C intake and dietary sources by demographic characteristics, Nutr. Cancer 10: 53–65.
Block, J., Chlebowski, R., and Dietrich, M., 1983, Potential for iapachol (NSC-11905) clinical trials reassessment with adjuvant quinone therapy, Med. Pediatr. Oncol. 11: 492A - 493A.
Boing, H., Martinez, L., Frentzel-Beyme, R., and Oltersdorf, U., 1985, Regional nutritional pattern and cancer mortality in the Federal Republic of Germany, Nutr. Cancer 7: 121–130.
Bollag, W., 1974, Therapeutic effects of an aromatic retinoic acid analog on chemically induced skin papillomas and carcinomas of mice, Eur. J. Cancer 10: 731–737.
Bollag, W., 1975, Prophylaxis of chemically-induced epithelial tumors with an aromatic retinoid acid analog, Eur. J. Cancer 11: 721–724.
Bollag, W., and Matter, A., 1981, From vitamin A to retinoids in experimental and clinical oncology, Ann. NY Acad. Sci. 27: 9–23.
Bond, G. G., Thompson, F. E., and Cook, R. R., 1987, Dietary vitamin A and lung cancer: Results of a case—control study among chemical workers, Nutr. Cancer 9: 109–121.
Borek, C., Ong, A., Mason, H., Donahue, L., and Biaglow, J. E., 1986, Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms, Proc. Natl. Acad. Sci. USA 83: 1490–1494.
Bosl, G., Whitmore, W., Myers, W., and Goldbey, R., 1983, Phase II trial of 13-cis-retinoic acid in the treatment of patients with advanced germ cell tumors, Proc. Am. Assoc. Cancer Res. 24: 150.
Brandes, D., Anton, E., Schofield, B., and Barnard, S., 1966, Role of lysosomal labilizers in treatment of mammary gland carcinomas with cyclophosphamide, Cancer Chemother. Rep. 50: 47–53.
Bright-See, E., 1983, Vitamin C and cancer prevention, Semin. Oncol. 10: 294–298.
Brock, K. E., Berry, G., Mock, P. A., MacLennan, R., Truswell, A. S., and Brinton, L. A., 1988, Nutrients in diet and plasma and risk of in situ cervical cancer, J. Natl. Cancer Inst. 80: 580–585.
Brown, R. R., Price, J. M., Friedell, G. H., and Burney, S. W., 1969, Tryptophan metabolism in patients with bladder cancer: Geographical differences, J. Natl. Cancer Inst. 53: 295–301.
Bryan, G. T., 1986, The influence of niacin and nicotinamide on in vivo carcinogenesis, Adv. Exp. Med. Biol. 206: 331–338.
Buamah, P. K., James, O. F., Skillen, A. W., and Harris, A. L., 1987, Serum vitamin B12 levels in patients with primary hepatocellular carcinoma during treatment with CB3717, J. Surg. Oncol. 34: 100–103.
Bulovskaia, L. N., 1976, Acetylation reaction in mice in the normal state and in tumors, Vopr. Onkol. 22: 59–63.
Byar, D., and Blackard, C., 1977, Comparisons of placebo, pyridoxine, and topical thiothepa in preventing recurrence of stage 1 bladder cancer, Urology 10: 556–561.
Byers, T., Marshall, J., and Graham, S., 1986, Dietary vitamin A and cancer—A multisite case-control study, Nutr. Cancer 8: 107–116.
Byers, T. E., Graham, S., Haughey, B. P., Marshall, J. R., and Swanson, M. K., 1987, Diet and lung cancer risk: findings from the Western New York Diet Study, Am. J. Epidemiol. 125: 351–363.
Cameron, E., and Campbell, A., 1974, The orthomolecular treatment of cancer. II. Clinical trial of high-dose ascorbic asid supplements in advanced human cancer, Chem. Biol. Interact. 9: 285–315.
Cameron, E., and Pauling, L., 1976, Supplemental ascorbate in the supportive treatment of cancer: Prolongation of survival times in terminal human cancer, Proc. Natl. Acad. Sci. USA 73: 3685–3689.
Cameron, E., and Pauling, L., 1979a, Supplemental ascorbate in the supportive treatment of cancer: Reevaluation of prolongation of survival times in terminal human cancer, Proc. Natl. Acad. Sci. USA 75: 4538–4542.
Cameron, E., and Pauling, L., 19796, Cancer and Vitamin C,Linus Pauling Institute of Science and Medicine, Menlow Park, CA.
Capel, I., Leach, D., and Dowell, H., 1983, Vitamin E retards the lipoperoxidation resulting from anticancer drug administration, Cancer Res. 43: 59–62.
Carmel, R., 1975, Extreme elevation of serum transcobalamin I in patients with metastatic cancer, N. Engl. J. Med. 292: 282–284.
Carmel, R., and Eisenberg, L., 1977, Serum vitamin B12 and transcobalamin abnormalities in patients with cancer, Cancer 40: 1348–1353.
Carpenter, M. P., 1986, Effects of vitamin E on the immune system, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 199–211.
Cassidy, J., Lippma, M., Lacroix, A., Peck, G., and Ozols, R., 1981, Phase II trial of 13-cis-retinoic acid in metastatic breast cancer and other malignancies, Proc. Am. Soc. Clin. Oncol. 23: 441.
Chabner, B. A., DeVita, V. T., Livingston, D. M., and Oliverio, V. T., 1970, Abnormalities of tryptophan metabolism and plasma pyridoxal phosphate in Hodgkin’s disease, N. Engl. J. Med. 282: 838–843.
Chang, M-D., Friedman, F. K., Beychok, S., Shyong, J. S., and Osserman, E. F., 1981, Further studies of the riboflavin-binding immunoglobulin IgGgar. Resolution onto fractions of different riboflavin content and aspects of assembly, Biochemistry 20: 2916–2921.
Chester, J. F., Gaissert, H. A., Ross, J. S., Malt, R. A., and Weitzman, S. A., 1986, Augmentation of 1,2dimethylhydrazine-induced colon cancer by experimental colitis in mice: Role of dietary vitamin E, J. Natl. Cancer Inst. 76: 939–942.
Chlebowski, R., Dietrich, M., Akman, S., and Block, J., 1983a, Vitamin K3 (menadione) inhibition of human tumor growth in the soft agar assay system, Proc. Am. Assoc. Cancer Res. 24: 563.
Chlebowski, R., Block, J., Dietriich, M., Octay, E., Barth, N., Yanagihara, R., Gota, C., and Ali, I., 1983b, Inhibition of human tumor growth and DNA biosynthetic activity by vitamin K and warfarin in vitro and clinical results, Proc. Am. Assoc. Cancer Res. 24: 653.
Choi, N. W., Miller, A. B., Fodor, J. G., Jain, M., Howe, G. R., Risch, H. A., and Ruder, A. M., 1987, Consumption of precursors of N-nitroso compounds and human gastric cancer, /ARC Sci. Publ. 1987 (84): 492–496.
Chow, C., Chen, L., Thacker, R., and Griffith, R., 1984, Dietary vitamin E and pulmonary biochemical responses of rats to cigarette smoking, Environ. Res. 34: 8–17.
Chu, B. C. F., and Lawley, P. D., 1975, Increased urinary excretion of nucleic acid and nicotinamide derivatives by rats after treatment with alkylating reagents, Chem.—Biol. Interact. 10: 333–338.
Clamon, G. H., Feld, R., Evans, W. K., Weiner, R. S., Kramer, B. S., Lininger, L. L., Gardner, L. B., Wolfe, E. C., DeWys, W. D., and Hoffman, F. A., 1984, Serum folate and vitamin Bi2 levels in patients with small cell lung cancer, Cancer 53: 306–310.
Clopath, P., Smith, V. C., and McCully, K. S., 1975, Growth promotion by homocysteic acid, Science 192: 372–374.
Cohen, M., 1972, Enhancement of the antitumor effect of 1,3-bis(2-chloroethyl)-1-nitrosurea by vitamin A and caffeine, J. Natl. Cancer Inst. 48: 927–932.
Cohen, M., and Carbone, P. P., 1972, Enhancement of the antitumor effects of 1,3-bis(2-chloroethyl)-1nitrosourea and cyclophosphamide by Vitamin A, J. Natl. Cancer Inst. 48: 921–922.
Cohen, M., Primack, A., Broder, L., and Williams, L., 1977, Vitamin A serum levels and dietary vitamin A intake in lung cancer patients, Cancer Lett. 4: 51–54.
Cohen, S., Wattenberg, J., and Bryan, G., 1976, Effect of avitaminosis A and hypervitaminosis A on urinary bladder carciongenicity of N4–5 nitro-2-furyl-2-thiazolyl formamide, Cancer Res. 36: 2334–2339.
Colditz, G. A., Stampfer, M. J., and Willett, W. C., 1987, Diet and lung cancer. A review of the epidemiologic evidence in humans, Arch. Intern. Med. 147: 157–160.
Coleman, J., III, Walker, A., and Didolkar, M., 1983, Treatment of adriamycin-induced skin ulcers: A prospective controlled study, J. Surg. Oncol. 22: 129–135.
Colston, K., and Coombes, R., 1985, Characterization of 1,25 dihydroxyvitamin D3 receptors in rat breast tumor, in: Vitamin D: Chemical, Biochemical, and Clinical Update, Proceedings of the Sixth Workshop on Vitamin D, Merano, Italy, ( A. W. Norman, K. Schaefer, H.-G. Grigoleit, and D. V. Herrath, eds.), Walter de Gruyter, New York, p. 895.
Colston, K., Colston, M., and Feldman, D., 1981, 1,25-Dihyroxyvitamin D3 and malignant melanoma, Endocrinology 108: 1083–86.
Committee on Diet, Nutrition, and Cancer, National Academy of Sciences, 1982, Diet, Nutrition, and Cancer, National Academy Press, Washington, DC.
Constantinides, P., and Harkey, M., 1985, Initiation of a transplantable fibrosarcoma by the synergism of two non-initiators, alpha-tocopherol and soya oil, Virchows Arch. 405: 285–297.
Cook, M., and McNamara, P., 1980, Effect of dietary vitamin Eon dimethylhydrazine-induced colonic tumors in mice, Cancer Res. 40: 1329–1331.
Corrocher, R., DeSandre, G., Ambrosetti, A., Pachor, M. L., Bambara, L. M., and Hoffbrand, A. V., 1978, Specific and non-specific folate binding protein in normal and malignant human tissues, J. Clin. Pathol. 31: 659–665.
Creagan, E. T., Moertel, C. G., O’Fallon, J. R., Shutt, A. J., O’Connell, M. J., Rubin, J., and Frytak, S., 1979, Failure of high-dose vitamin C (ascorbic acid) therapy to benefit patients with advanced cancer, N. Engl. J. Med. 301: 687–690.
Crepaldi, G., and Parpajola, A., 1964, Excretion of tryptophan metabolites in different forms of haemoblastosis, Clin. Chim. Acta 9: 106–117.
Daenen, S., Vellenga, E., van Dobbenburgh, O. A., and Halie, M. R., 1986, Retinoic acid as antileukemic therapy in a patient with acute promelocytic leukemia and Aspergillus pneumonia, Blood 67: 559–561.
Davies, D., 1967, Effect of vitamin A on 7,12-dimethylbene(a)anthracene-induced papillomas in rhino mouse skin, Cancer Res. 27: 237–241.
Dawson, E., Nosovitch, J., and Hannigan, E., 1984, Serum vitamin and selenium changes in cervical dysplasia, Fed. Proc. 43: 1914.
Day, P. L., Payne, L. D., and Dinning, J. S., 1960, Procarcinogenic effect of vitamin B12 on p-dimethylaminofed rats, Proc. Soc. Exp. Biol. Med. 74: 854–857.
DeLuca, H. F., and Ostrem, V., 1986, The relationship between the vitamin D system and cancer, Adv. Exp. Med. Biol. 206: 413–429.
De Reuck, J. L., Sieben, G. J., Sieben-Praet, M. R., Ngendahayo, P., De Coster, J. P., and Vander Eecken, H. M., 1980, Wemicke’s encephalopathy in patients with tumors of the lymphoidc systems, Arch. Neurol. 37: 338–341.
DiSorbo, D. M., Paavola, L. G., and Litwack, G., 1982, Pyridoxine resistance in a rat hepatoma cell line, Cancer Res. 42: 2362–2370.
DiSorbo, D. M., Wagner, R., Jr., and Nathanson, L., 1985, In vivo and in vitro inhibition of B16 melanoma growth by vitamin B6, Nutr. Cancer 7: 43–52.
Dorr, R., and Alberts, D., 1983, Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse, Cancer Treat. Rep. 67: 499–501.
Douglas, J. F., Huff, J., and Peters, A. C., 1984, No evidence of carcinogenicity of L-ascorbic acid (vitamin C) for rodents, J. Toxicol. Env. Health 14: 605–609.
Eichner, E. R., McDonald, C. R., and Dickson, B. A., 1978, Elevated serum levels of unsaturated folate binding protein: Clinical correlates in a general hospital population, Am. J. Clin. Nutr. 31: 1988–1992.
Eisman, J., 1985, Regulation of human target cell response to 1,25 dihyroxyvitamin D3, in: Vitamin D: Chemical, Biochemical, and Clinical Update, Proceedings of the Sixth Workshop on Vitamin D, Merano, Italy, ( A. W. Norman, K. Schaefer, H.-G. Grigoleit, and D. V. Herrath, eds.), Walter de Gruyter, New York, pp. 879–886.
Eisman, J., Maclntyre, I., Martin, T., and Frampton, R., 1980a, Normal and malignant breast tissue is a target organ for I,25(OH)2 vitamin D3, Clin. Endocrinol. 13: 267–272.
Eisman, J., Martin, T., Maclntyre, I., Frampton, R., Mosley, J., and Whitehead, R., 1980b, 1,25-Dihydroxyvitamin D3 receptor in a cultured human breast cancer cell line, Biochem. Biophys. Res. Commun. 93: 915.
Englard, S., and Seifter, S., 1986, The biochemical functions of ascorbic acid, Annu. Rev. Nutr. 6: 365–406.
Enstrom, J. E., Kanim, L. E., and Breslow, L., 1986, The relationship between vitamin C intake, general health practices, and mortality in Alameda County, California, Am. J. Public Health 76: 1124–1130.
Epstein, J., 1977, Chemicals and photocarcinogenesis, Aust. J. Dermatol. 18: 57–61.
Epstein, J., and Grenkin, D., 1981, Inhibition of ultraviolet-induced carcinogenesis by all-trans retinoic acid, J. Invest. Dermatol. 76: 178–180.
Epstein, S., Joshi, S., Andrea, J., Forsyth, J., and Mantel, N., 1967, The null effect of antioxidants on the carcinogenecity of 3,4,9,10-dibenzpyrene to mice, Life Sci. 6: 225–233.
Erbe, R. W., and Wang, J-C. C., 1984, Folate metabolism in humans, Am. J. Genet. 17: 277–287.
Eto, I., and Krumdieck, C. L., 1986, Role of vitamin B12 and folate deficiencies in carcinogenesis, Adv. Exp. Med. Biol. 206: 313–330.
Evans, C., and Todd, I., 1969, Synkavite and radiotherapy in the treatment of bronchial carcinoma: A randomized trial, Clin. Radiol. 20: 228–230.
Farhangi, M., and Osserman, E. F., 1976, Myeloma with xanthoderma due to an IgG monoclonal anti-flavin antibody, N. Engl. J. Med. 294: 177–183.
Fiddler, W., Pensabene, J., Piotrowski, E., Philips, J., Keatining, J., Mergens, W., and Newmark, H., 1978, Inhibition of formation of volatile nitrosamines in fried bacon by the use of cure-solubilized alphatocopherol, J. Agric. Food Chem. 26: 653–56.
Fontana, J. A., Rogers, J. S., and Durham, J. P., 1986, The role of 13 cis-retinoic acid in the remission induction of a patient with acute promyelocytic leukemia, Cancer 57: 209–217.
Foy, H., and Kondi, A., 1984, The vulnerable esophagus: Riboflavin deficiency and squamous cell dysplasia of the skin and the esophagus, J. Natl. Cancer Inst. 72: 941–948.
Foy, H., and Mbaya, V., 1977, Riboflavin, Frog. Food Nutr. Sci. 2: 357–394.
Foy, H., Kondi, A., Davies, J. N. P., Anderson, B., Parker, A., Preston, J., and Peers, F. J., 1974, Histologic changes in livers of pyridoxine-deprived baboons—Relation to alpha-fetoprotein and liver cancer in Africa, J. Natl. Cancer Inst. 53: 1295–1311.
Frampton, R., Suva, L., Eisman, J., Findley, D., Moore, G., Moseley, J., and Martin, T., 1982, Presence of 1,25-dihydroxyvitamin D3 receptors in established human cancer cell lines in culture, Cancer Res. 42: 1116–1119.
Freake, H., Marocci, C., Iwasaki, J., and Maclntyre, I., 1981, 1,25-Dihydroxyvitamin D3 specifically binds to a human breast cancer cell line and stimulates growth, Biochem. Biophys. Res. Commun. 101: 113–1138.
Fujimaki, I., 1926, Formation of carcinoma in albino rats fed on deficient diets, J. Cancer Res. 10: 469–477.
Fujiyama, S., Morishita, T., Hashiguchi, O., and Sato, T., 1988, Plasma abnormal prothrombin (des-gammacarboxy prothrombin) as a marker of hepatocellular carcinoma, Cancer 61: 1621–16288.
Fukushima, S., Shibata, M. A., Shirai, T., Tamano, S., and Ito, N., 1986, Roles of urinary sodium ion concentration and pH in promotion by ascorbic acid of urinary bladder carcinogenesis in rats, Cancer Res. 46: 1623–1626.
Gailani, S. D., Holland, N. F., Nussbaum, A., and Olson, K. B., 1968, Chemical and biochemical studies of pyridoxine deficiency in patients with neoplastic diseases, Cancer 21: 975–988.
Garland, C., and Garland, F., 1980, Do sunlight and vitamin D reduce the likelihood of colon cancer? Int. J. Epidemiol. 9: 227–231.
Garland, C., Shekelle, R., Barrett-Connor, B., Criqui, M., Rossof, A., and Oglesby, P., 1985, Dietary vitamin D and calcium and risk of colorectal cancer, Lancet 1: 307–309.
Ghosh, J., and Das, S., 1985, Evaluation of vitamin A and C status in normal and malignant conditions and their possible role in cancer prevention, Jpn. J. Cancer Res. 76: 1174–1178.
Ghoshal, A. K., and Farber, E., 1984, The induction of liver cancer by dietary deficiency of choline and methionine without added carcinogens, Carcinogenesis 5: 1367–1370.
Ghoshal, A. K., Ahluwalia, M., and Farber, E., 1983, The rapid induction of liver cell death in rats fed a choline-deficient methionine low diet, Am. J. Pathol. 113: 309–314.
Giambarresi, L. I., Katyal, S. L., and Lambardi, B., 1982, Promotion of liver carcinogenesis in the rat by a choline-devoid diet: Role of liver cell necrosis and regeneration, Br. J. Cancer 46: 825–829.
Gold, E., Mertelsmann, R., Itri, L., Gee, T., Arlen, Z., Kemplin, S., Clarkson, B., and Moore, M., 1983, Phase I clinical trial of 13-cis-retinoic acid in myelodysplasitc syndromes, Cancer Treat. Rep. 67: 981–986.
Gold, J., 1986, In vivo synergy of vitamin K3 and methotrexate in tumor-bearing animals, Cancer Treat. Rep. 70: 1433–1435.
Goodman, G., Alberts, D., Ernst, D., and Meyskens, F., Jr., 1983, Phase I trial of retinol in cancer patients, J. Clin. Oncol. 1: 394–399.
Goodwin, T. W., 1986, Metabolism, nutrition, and function of carotenoids, Annu. Rev. Nutr. 6: 273–297.
Gouveia, J., Mathew, G., Hergend, T., Gros, F., Lemaigre, G., and Santelli, G., 1982, Degree of bronchial metaplasia in heavy smokers and its regression after treatment with retinoid, Lancet 2: 710–712.
Grassetti, D. R., 1986, The antimetastatic and tumor growth retarding effects of sulfur containing analogs of nicotinamide, Cancer Lett. 31: 187–195.
Gregor, A., Lee, P., Roe, J., Wilson, M., and Melton, A., 1980, Comparison of dietary histories in lung cancer cases and controls with special reference to Vitamin A, Nutr. Cancer 2: 93–97.
Gregory, J. F., III, and Kirk, J. R., 1981, The bioavailability of vitamin B6 in foods, Nutr. Rev. 37: 1–8.
Gridley, D. S., Stickney, D. R., Nutter, R. L., Slater, J. M., and Shultz, T. I., 1987, Suppression of tumor growth and enhancement of immune status with high levels of dietary vitamin B6 in BALB/c mice, J. Natl. Cancer Inst. 78: 951–959.
Grosse, W., III, and Wade, A. E., 1971, The effects of thiamine consumption on liver microsomal drug-metabolizing pathways, J. Pharmacol. Exp. Ther. 176: 758–768.
Ha, C., Kerkvilet, N. I., Miller, L. T., 1984, The effect of vitamin B6 dificiency on host susceptibility to Maloney sarcoma virus-induced tumor growth in mice, J. Nutr. 114: 938–945.
Haber, S., and Wissler, R., 1962, Effect of vitamin E on carcinogenicity of methylcholanthrene, Proc. Soc. Exp. Biol. Med. 111: 774–775.
Haenszel, W., Correa, P., Lopez, A., Cuello, C., Zarama, G., and Fontham, E., 1985, Serum micronutrient levels in relation to gastric pathology, Int. J. Cancer 36: 43–48.
Hall, C. A., and Wanko, M., 1971, Increased transcobalamin I in a leukemoid reaction, J. Lab. Clin. Med. 78: 298–301.
Halpern, R., Halpern, B. C., Stea, B., Dunlap, A., Conklin, K., Clark, B., Ashe, H., Sperling, L., Halpern, J. A., Hardy, D., and Smith, R. A., 1977, Pterin-6-aldehyde. A cancer cell catabolite: Identification and application in diagnosis and treatment of human cancer, Proc. Natl. Acad. Sci. USA 74: 587–591.
Hanck, A., 1986, Ascorbic acid and cancer, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 365–397.
Hanck, A. B., 1988, Vitamin C and cancer, Prog. Clin. Biol. Res. 259: 307–320.
Hara, T., and Taniguchi, M., 1985, Relationship between the changes in properties and contents of riboflavin derivatives of NADPH—cytochrome P450 reductase in liver microsomes of riboflavin-deficient rats, J. Biochem. (Tokyo) 97: 473–482.
Harada, T., Kitazawa, T., Maita, K., and Shirasu, Y., 1985, Effects of vitamin C on tumor induction by diethylnitrosamine in the respiratory tract of hamsters exposed to cigarette smoke, Cancer Lett. 25: 163–169.
Harmon, D., 1969, Dimethylbenzanthracene induced cancer: Inhibiting effect of dietary vitamin E, Clin. Res. 17: 125.
Hausen, A., Fuchs, D., Grunewald, K., Huber, H., Konig, K., and Wachter, H., 1982, Urinary neopterine in the assessment of lymphoid and myeloid neoplasia and neopterine levels in haemolytic anemia and benign monoclonal gammopathy, Clin. Biochem. 15: 34–37.
Haussier, C. A., Marion, S. L., Pike, J. W., and Haussier, M. R., 1986, 1,25-Dihydroxyvitamin D3 inhibits the clonogenic growth of transformed cells via its receptor, Biochem. Biophys. Res. Commun. 139: 136–143.
Haydey, R., Reed, M., Dzubow, L., and Shupack, J., 1980, Treatment of keratocanthomas with oral 13-cisretinoic acid, N. Engl. J. Med. 303: 560–562.
Heimburger, D. C.. Alexander, C. B., Birch, R., Butterworth, C. E., Jr., Bailey, W. C., and Krumdieck, C. L., 1988, Improvement in bronchial squamous metaplasia in smokers treated with folate and vitamin B12. Report of a preliminary randomized, double-blind intervention trial, JAMA 259: 1525–1530.
Hellman, S., Ianotti, A. T., and Bertino, J. R., 1964, Determinations of the levels of serum folate in patients with carcinoma of the head and neck treated with methotrexate, Cancer Res. 24: 105–113.
Helson, L., 1984, A trial of vitamin E in neuroectodermal tumors, Proc. Am. Soc. Clin. Oncol. 3: 80.
Henderson, L. M., 1983, Niacin, Annu. Rev. Nutr. 3: 289–307.
Herbert, V., 1986, The role of vitamin B12 and folate in carcinogenesis, Adv. Exp. Med. Biol. 206: 293–311.
Hill, D. L., and Grubbs, C. J., 1982, Retinoids as chemopreventive and anticancer agents in intact animals, Anticancer Res. 2: 111–124.
Hinds, M., Kolonel, L., Rankin, J., and Lee, J., 1984, Dietary vitamin A, carotene, vitamin C, and risk of lung cancer in Hawaii, Am. J. Epidemiol. 119: 227–237.
Hirano, H., Hamajima, S., Horiiuchi, S., Niitsu, Y., and Ono, S., 1983, Effects of B2-deficiency on lipoperoxide and its scavenging system in the rat lens, Int. J. Vit. Nutr. Res. 53: 377–382.
Hirayama, T., 1979, Diet and cancer, Nutr. Cancer 1: 67–81.
Hoffman, F. A., 1985, Micronutrient requirements of cancer patients, Cancer 55: 295–300.
Hoogstraten, B., Baker, H., and Reizenstein, R., 1961, Correlation between serum folic acid activity and response to anti-folate therapy, Blood 18: 787.
Hoover, K. L., Lynch, P. H., and Poirier, L. A., 1984, Profound postinitiation enhancement by short-term severe methionine, choline, vitamin B12, and folate deficiency of hepatocarcinogenesis in F344 rats given a single low-dose diethylnitrosamine injection, J. Natl. Cancer Inst. 73: 1327–1336.
Horiuchi, S., and Ono, S., 1984, Effects of riboflavin administration on the phospholipid metabolism of rat liver impaired with carbon tetrachloride, Int. J. Vit. Nutr. Res. 54: 173–177.
Horsman, M. R., Chaplin, D. J., and Brown, J. M., 1987, Radiosensitization by nicotinamide in vivo: A greater enhancement of tumor damage compared to that of normal tissues, Radiat. Res. 109: 479–489.
Horwitt, M., 1980, Therapeutic uses of vitamin E in medicine, Nutr. Rev. 38: 105–113.
Horwitt, M. K., 1986, The promotion of vitamin E, J. Nutr. 116: 1371–1377.
Howard, W. B., and Willhite, C. C., 1986, Toxicity of retinoids in humans and animals, J. Toxicol.—Toxin Rev. 5: 55–94.
Hulshof, K. F., Gooskens, A. C., Wedel, M., and Bruning, P. F., 1987, Food intake in three groups of cancer patients. A prospective study during cancer treatment, Hum. Nutr. Appl. Nutr. 41: 23–37.
Inculet, R. I., Norton, J. A., Nichoalds, G. E., Maher, M. M., White, D. E., and Brennan, M. F., 1987, Water-soluble vitamins in cancer patients on parenteral nutrition: A prospective study, J. Parenter. Enter. Nutr. 11: 243–249.
Ink, S. L., and Henderson, L. M., 1984, Vitamin B6 metabolism, Annu. Rev. Nutr. 4: 455–470.
Innis, W. S. A., McCormick, D. B., and Merrill, A. H., Jr., 1985, Variations in riboflavin binding by human plasma: Identification of immunoglobulins as the major proteins responsible, Biochem. Med. 34: 151–165.
Innis, W. S. A., Nixon, D. W., Murray, D. R., McCormick, D. B., and Merrill, A. H., Jr., 1986, Immunoglobulins associated with elevated riboflavin binding by plasma from cancer patients, Proc. Soc. Exp. Biol. Med. 181: 237–241.
Ip, C., 1982, Dietary vitamin E and mammary carcinogenesis in rats, Carcinogenesis 3: 1453–1456.
Ip, C., 1988, Feasibility of using lower doses of chemopreventive agents in a combination regimen for cancer protection, Cancer Lett. 39: 239–246.
Israels, L., Walls, G., Ollmann, D., Friesen, E., and Israels, E., 1983, Vitamin K as a regulator of benzo(a)pyrene metabolism, mutagenesis, and carcinogenesis, J. Clin. Invest. 71: 1130–1140.
Ito, Y., 1981, Effect of an aromatic retinoic acid analog on growth of virus-induced papilloma and related neoplasias of rabbits, Eur. J. Cancer 17: 35–42.
Jacobson, E. L., Smith, J. Y., Mingmuang, M., Meadows, R., Sims, J. L., and Jacobson, M. K., 1984, Effect of nicotinamide analogues on recovery from DNA damage in C3H10T1/2 cells, Cancer Res. 44: 2485–2492.
Jacobson, M. K., Levi, V., Juarez-Salinas, H., Barton, R. A., and Jacobson, E. L., 1980, Effect of carcinogenic N-alkyl-N-nitroso compounds on nicotinamide adenine dinucleotide metabolism, Cancer Res. 40: 1797–1802.
Jaffe, W., 1946, The influence of wheat germ oil on the production of tumors in rats by methylcholanthrene, Exp. Med. Surg. 4: 278–282.
Kagan, Y. A., 1957, The effect of internal administration of riboflavine on the content of riboflavine in the urine of cancer patients, Patol. Fiziol. Eksp. Ter. 1: 44 48.
Kagan, Y. A., 1960, Riboflavin determination in the urine of patients suffering from malignant neoplasms, Khirurgiya 2: 103–108.
Kagerud, A., and Peterson, H., 1981, Tocopherol in tumor irradiation, Anticancer Res. 1: 35–38.
Kagerud, A., Klintenberg, C., Lund, N., and Peterson, H., 1980, Influence of tocopherol on tumor cell oxygenation, Cancer Lett. 5: 185–9.
Kamiyama, S., Ohshima, H., Shimada, A., Saito, N., Bourgade, M. C., Ziegler, P., and Bartsch, H., 1987, Urinary excretion of N-nitrosamino acids and nitrate by inhabitants in high-and low-risk areas for stomach cancer in northern Japan, IARC Sci. Publ. 1987 (84): 497–502.
Kaplan, H. S., and Rigler, L. G., 1945, Pernicious anemia and carcinoma of the stomach. Autopsy studies concerning their interrelationship, Am. J. Med. Sci. 209: 339–348.
Kaplan, I. I., 1944, One year observation of the treatment of cancer with avidin (egg white), Am. J. Med. Sci. 207: 733–743.
Kark, J., Smith, A., Sitzer, B., and Hames, C., 1981, Serum vitamin A and cancer incidence in Evans County, Georgia, J. Natl. Cancer Inst. 66: 7–16.
Kato, T., Suzumura, Y., and Fukushima, M., 1988, Enhancement of blemoycin activity by 3-aminobenzamide, a poly (ADP-ribose) synthesis inhibitor, in vitro and in vivo, Anticancer Res. 8: 239–243.
Katsouyanni, K., Willett, W., Trichopoulos, D., Boyle, P., Trichopoulou, A., Vasilaros, S., Papadiamantis, J., and MacMahon, B., 1988, Risk of breast cancer among Greek women in relation to nutrient intake, Cancer 61: 181–185.
Kaul, L., Heshmat, M. Y., Kovi, J., Jackson, M. A., Jackson, A. G., Jones, G. W., Edson, M., Enterline, J. P., Worrell, R. G., and Perry, S. L., 1987, The role of diet in prostate cancer, Nutr. Cancer 9: 123–128.
Kayden, H., Hatam, L., and Traber, M., 1984, Reduced tocopherol content of B cells from patients with chronic lymphocytic leukemia, Blood 63: 213–215.
Kazarinoff, M. N., and McCormick, D. B., 1975, Rabbit liver pyridoxamine (pyridoxine) 5’-phosphate oxidase: Purification and properties, J. Biol. Chem. 250: 3436–3442.
Kensler, C. J., Sugiura, K., Young, N. F., Halter, C. R., and Rhoads, C. P., 1941, Partial protection of rats by riboflavin with casein against liver cancer caused by dimethylaminobenzene, Science 93: 308–310.
Kiefer, C. R., McGuire, B. S., Osserman, E. F., and Garver, F. A., 1983, The modeled structure of the IgGGar VL region and its implications for anti-flavin and anti-DNP fine specificities, J. Immunol. 131: 1871–1875.
King, M., and McCay, P., 1983, Modulation of tumor incidence and possible mechanism of inhibition of mammary carcinogenesis by dietary antioxidants, Cancer Res. 43: 2485–2490.
Kinn, A-C., and Lantz, B., 1984, Vitamin B12 deficiency after irradiation for bladder carcinoma, J. Urol. 131: 888–890.
Kirkemo, A. K., Burt, M. E., and Brennan, M. F., 1982, Serum vitamin level maintenance in cancer patients on total parenteral nutrition, Am. J. Clin. Nutr. 35: 1003–1009.
Kjellen, E., Pero, R. W., Cameron, R., and Ranstam, J., 1986, Radiosensitizing effects of nicotinamide on a C3H mouse mammary adenocarcinoma. A study on per os drug administration, Acta Radio!. (Oncol.) 25: 281–284.
Kline, B. E., Rusch, H. P., Bauman, C. A., and Lavik, P. S., 1943, The effect of pyridoxine on tumor growth, Cancer Res. 3: 825–829.
Kline, B. E., Miller, J. A., and Rusche, H. P., 1945, Certain effects of egg white and biotin on the carcinogenicity of p-dimethylaminoazobenzene in rats fed a sub-protective level of riboflavin, Cancer Res. 5: 641–643.
Knekt, P., Aromaa, A., Maatela, J., Aaran, R. K., Nikkari, T., Hakama, M., Hakulinen, T., Peto, R., Saxen, E., and Teppo, L., 1988, Serum vitamin E and risk of cancer among Finnish men during a 10-year follow-up, Am. J. Epidemiol. 127: 28–41.
Koch, H., 1978, Biochemical treatment of precancerous oral lesions: The effectiveness of various analogs of retinoic acid, J. Max-Fac. Surg. 6: 59–63.
Kokolis, N., and Ziegler, I., 1977, On the levels of phenylalanine, tyrosine, and tetrahydrobiopterin in the blood of tumor-bearing organisms, Cancer Biochem. Biophys. 2: 79–85.
Kolonel, L. N., Hankin, J. H., and Yoshizawa, C. N., 1987, Vitamin A and prostate cancer in elderly men: Enhancement of risk, Cancer Res. 47: 2982–2985.
Korpela, J., 1984, Avidin, a high affinity biotin-binding protein, as a tool and subject of biological research, Med. Biol. 62: 5–26.
Korytnyk, W., 1979, Synthesis and biological activity of vitamin B6 analogs, Meth. Enzymol. 62: 454–483.
Kozik, A., and McCormick, D. B., 1984, Mechanism of pyridoxine uptake by isolated rat liver cells, Arch. Biochem. Biophys. 229: 187–193.
Krishnamurthi, S., Shanta, V., and Sastri, D., 1971, Combined therapy in bucal mucosal cancers, Radiology 99: 409–415.
Kull, F. C., Jr., Brent, D. A., Parikh, I., and Cuatrecasas, P., 1987, Chemical identification of a tumor-derived angiogenic factor, Science 236: 843–845.
Kune, S., Kune, G. A., and Watson, L. F., 1987, Case—control study of dietary etiological factors: The Melbourne Colorectal Cancer Study, Nutr. Cancer 9: 21–42.
Kurl, R. N., and Villee, C. A., 1985, A metabolite of riboflavin binds to the 2,3,7,8-tetrachlorodibenzo-pdioxin (TCDD) receptor, Pharmacology 30: 241–244.
Kvale, G., Bjelke, E., and Gart, J., 1983, Dietary habits and lung cancer risk, Br. J. Cancer 31: 397–405.
Kyle, R., and Jowsey, J., 1980, Effect of sodium fluoride, calcium carbonate and vitamin D on the skeleton in multiple myeloma, Cancer 45: 1669–1674.
Ladner, H. A., and Holtz, F., 1979, Zum verhalten einiger B-vitamine nach strahlen und/oder zytostatikabehandlung gynakolischer karzinome, Strahlentherapie 75: 191–195.
Ladner, H. A., and Salkeld, R. M., 1988, Vitamin B6 status in cancer patients: Effect of tumor site, irradiation, hormones and chemotherapy, Prog. Clin. Biol. Res. 259: 273–281.
Lane, M., 1971, Induced riboflavin deficiency in treatment of patients with lymphomas and polycythemia vera, Proc. Am. Assoc. Cancer Res. 12: 85.
Lawson, T., 1983, Nicotinamide stimulates the repair of carcinogen-induced DNA damage in the hamster pancreas in vitro, Anticancer Res. 3: 207–210.
Lea, M. A., Barra, R., and Randolph, V., 1984, Effects of nicotinamide and structural analogs on DNA synthesis and cellular replication of rat hepatoma cells, Cancer Biochem. Biophys. 7: 195–202.
Lee, C., and Chen, C., 1979, Enhancement of mammary tumorigenesis in rats by vitamin E deficiency, Proc. Am. Assoc. Cancer Res. 20: 132.
Lenzen, S., Koppel, G., and Panten, U., 1985, Secretory, enzymatic, and morphological characterization of rat pancreatic endocrine tumours induced by streptozotocin and nicotinamide, Acta Endocrinol. 109: 361–368.
Levij, I. S., and Pollack, M. B., 1968, Potentiating effect of vitamin A on 9–10 dimethyl, 1,2-benzathracenecarcinogenesis in the hamster cheek pouch, Cancer 22: 300–306.
Levine, N., and Meyskens, F., 1980, Topical vitamin-A-acid therapy for cutaneous metastatic melanoma, Lancet 2: 224–226.
Loescher, L., and Sauer, K., 1984, Vitamin therapy for advanced cancers, Oncol. Nurs. Forum 11: 38–45.
Lombardi, B., and Shinozuka, H., 1979, Enhancement of 2-AAF liver carcinogenesis in rats fed a choline-deficient diet, Int. J. Cancer 23: 565–570.
London, R., Sundaram, G., and Schultz, M., 1981, Endocrine parameters and alpha-tocopherol therapy of patients with mammary dysplasia, Cancer Res. 41: 3811–3813.
Lopez, S., and LeGardeur, B., 1982, Vitamin A, C, and E in relation to lung cancer incidence, Am. J. Clin. Nutr. 35: 851.
Lopez, S., LeGarrdeur, B., and Johnson, W., 1981, Vitamin A status and lung cancer, Am. J. Clin. Nutr. 34: 641.
Lu, S. H., Ohshima, H., Fu, H. M., Tian, Y., Li, F. M., Blettner, M., Wahrendorf, J., and Bartsch, H., 1986, Urinary excretion of N-nitrosoamino acids and nitrate by inhabitants of high-and low-risk areas for esophageal cancer in Northern China: Endogenous formation of nitrosoproline and its inhibition by vitamin C, Cancer Res. 46: 1485–1491.
Ludgate, S. M., and Merrick, M. V., 1985, The pathogenesis of post-irradiation chronic diarrhea: Measurement of SeHCAT and B12 adsorption for differential diagnosis determines treatment, Clin. Radiol. 36: 275–278.
Lutzner, M., and Blanchet-Bardon, C., 1980, Oral retinoid treatment of human papillomavirus type 5 induced epidermodysplasia verruciformis, N. Engl. J. Med. 302: 1091.
Lyon, J. L., Mahoney, A. W., West, D. W., Gardner, J. W., Smith, K. R., Sorenson, A. W., and Stanish, W., 1987, Energy intake: Its relationship to colon cancer risk, J. Natl. Cancer Inst. 78: 853–861.
MacLennon, R., Dacosta, J., Day, N., Law, C., Ng, Y., and Shanmugarartnam, K., 1977, Risk factors for lung cancer in Singapore Chinese, Int. J. Cancer 20: 854–860.
Mahmoud, L., and Robinson, W., 1982, Vitamin A levels in human bladder cancer, Int. J. Cancer 30: 143–145.
Malick, M., Roy, R., and Sternberg, J., 1978, Effect of vitamin Eon post-irradiation death in mice, Experiential 34: 1216–1217.
Manolagas, S. C., 1987, Vitamin D and its relevance to cancer, Anticancer Res. 7: 625–638.
Marcus, S. L., Dutcher, J. P., Paietta, E., Ciobanu, N., Strauman, J., Wiemik, P. H., Hutner, S. H., Frank, O., and Baker, H., 1987, Severe hypovitaminosis C occurring as the result of adoptive immunotherapy with high-dose interleukin 2 and lymphokine-activated killer cells, Cancer Res. 47: 4208–4212.
Marshall, J., Graham, S., and Mettlin, C., 1982, Diet in the epidemiology of oral cancer, Nutr. Cancer 3: 145–149.
Martin, T., Findlay, D., Maclntyre, I., Eisamn, J., Michelangeli, V., Moseley, J., and Partridge, N., 1980, Calcitonin receptors in a cloned human breast cancer cell line, Biochem. Biophys. Res. Commun. 96: 150–156.
Marubini, E., Decarli, A., Costa, A., Mazzoleni, C., Andreoli, C., Barbieri, A., Capitelli, E., Carlucci, M., Cavallo, F., Monferroni, N., Pastorino, U., and Salvini, S., 1988, The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer. Results of a case-control study, Cancer 61: 173–180.
McCay, P. B., 1985, Vitamin E: Interaction with free radicals and ascorbate, Annu. Rev. Nutr. 5: 323–340.
McCormick, D., Burns, F., and Albert, R., 1980, Inhibition of rat mammary carcinogenesis by short dietary exposure to retinyl acetate, Cancer Res. 40: 1140–1143.
McCormick, D. L., May, C. M., Thomas, C. F., and Detrisac, C. J., 1986, Anticarcinogenic and hepatotoxic interactions between retinyl acetate and butylated hydroxytoluene in rats, Cancer Res. 46: 5264–5269.
Meister, N. T., and Thanassi, J. W., 1988, Vitamin B6 metabolism in McA-RH7777 cells, Cancer Res. 48: 1080–1085.
Mendelson, R. W., Watkin, D. M., Horbett, A. P., and Fahey, J. L., 1958, Identification of the vitamin B12-binding protein in the serum of normals and of patients with chronic myelocytic leukemia, Blood 13: 740747.
Menkes, M., and Comstock, J., 1984, Vitamins A and E and lung cancer, Am. J. Epidemiol. 120: 491.
Menkes, M. S., Comstock, G. W., Vuilleumier, J. P., Helsing, K. J., Rider, A. A., and Brookmeyer, R., 1986, Serum beta-carotene, vitamins A and E, selenium, and the risk of lung cancer, N. Engl. J. Med. 315: 1250–1254.
Mergens, W., Vane, F., Tannenbaum, S., Green, L., and Skipper, P., 1979, In vitro nitrosation of methapyrilene, J. Pharm. Sci. 68: 827–832.
Merrill, A. H., Jr., and Henderson, J. M., 1987, Diseases associated with defects in vitamin B6 metabolism or utilization, Annu. Rev. Nutr. 7: 137–156.
Merrill, A. H., Jr., and McCormick, D. B., 1980, Affinity chromatographic purification and properties of flavokinase (ATP:riboflavin 5 ’-phosphotransferase) from rat liver, J. Biol. Chem. 255: 1335–1338.
Merrill, A. H., Jr., Lambeth, J. D., Edmondson, D. E., and McCormick, D. B., 1981, Formation and mode of action of flavoproteins, Annu. Rev. Nutr. 1: 281–317.
Mettlin, C., 1986, Changing the public’s health behaviors by diet and chemopreventive interventions, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 257–266.
Mettlin, C., and Graham, S., 1979, Dietary risk factors in human bladder cancer, Am. J. Epidemiol. 110: 255–263.
Mettlin, C., Graham, S., and Swanson, M., 1979, Vitamin A and lung cancer, J. Natl. Cancer Inst. 62: 1435–1438.
Meyer, L. M., Bertcher, R. W., Cronkite, E. P., Suarez, R. M., Miller, I. F., Mulzac, I. F., and Olivarreta, S. T., 1961, Co60 vitamin 1312 binding capacity of serum in persons with hematologic disorders, various medical diseases and neoplasms, Acta Med. Scand. 169: 557–575.
Meyskens, F. L., and Prasad, K. N. (eds.), 1986, Vitamins and Cancer, Humana Press, Clifton, NJ. Meyskens, Jr., F., Gilmartin, E., Alberts, D., Levine, N., Brooks, R., Daimon, S., and Surwit, E., 1982, Activity of isoretinoin against squamous cell cancers and preneoplastic lesions, Cancer Treat. Rep. 66: 1315–1319.
Mickshe, M., Cemi, C., Kokron, O., Titscher, R., and Wrba, H., 1977, Stimulation of immune response in lung cancer patients by vitamin A therapy, Oncology 34: 234–238.
Mihich, E., and Nichol, C. A., 1959, The effect of pyridoxine deficiency on mouse sarcoma 180, Cancer Res. 19: 279–284.
Mikol, Y. B., Hoover, K. L., Creasia, D., and Poirier, L. A., 1983, Hepatocarcinogenesis in rats fed methyl-deficient, amino acid-defined diets, Carcinogenesis 4: 1619–1629.
Miller, E. G., and Burns, H., Jr., 1984, N-Nitrosodimethylamine carcinogenesis in nicotinamide-deficient rats, Cancer Res. 44: 1478–1482.
Miller, J. A., and Miller, E. C., 1953, The carcinogenic aminoazo dyes, Adv. Cancer Res. 1:339–396. Mills, E., 1983, The role of vitamin A in cancer, South Afr. Med. J. 63: 74–77.
Mirvish, S. S., 1986, Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer, Cancer 58 (Suppl.): 1842–1850.
Mitchell, J., 1960, Clinical assessment of tetra-sodium 2-methyl-1,4-napthahydroquinone diphosphate as a radiosensitizer in the radiotherapy of malignant tumors, Br. J. Cancer 7: 140.
Mitchell, J., Brinkley, D., and Haybrittle, J., 1965, Clinical trial of radiosensitizers, including synkavit and oxygen inhales at atmospheric pressure, Acta Radiol. Ther. Physiol. Biol. 3: 329–341.
Miyata, Y., Fukushima, S., Hirose, M., Masui, T., and Ito, N., 1985, Short-term screening of promoters of bladder carcionogenesis in N-butyl-N-(4-hydroxybutyl)nitrosamine-initiated, unilaterally ureter-ligated rats, Jpn. J. Cancer Res. 76: 828–834.
Miyaura, C., Abe, E., Koribayashi, T., Tanaka, H., Konno, K., Nishii, Y., and Suda, T., 1981, la,25Dihydroxyvitamin D3 induces differentiation of human myeloid leukemia cells, Biochem. Biophys. Res. Comm. 102: 937–943.
Moertel, C. G., Fleming, T. R., Creagan, E. T., Rubin, J., O’Connell, M. J., and Ames, M. M., 1985, High-dose vitamin C versus placebo in the treatment of patients with advanced cancer who have had no prior chemotherapy, N. Engl. J. Med. 312: 137–141.
Moon, R., Grubbs, C., Spron, M., and Goodman, D., 1977, Retinyl acetate inhibits mammary carcinogenesis induced by N-methyly-N-nitrosurea, Nature 267: 620–621.
Moon, R. C., McCormick, D. L., and Mehta, R. G., 1986a, Retinoids as chemotherapeutic agents: Alone and in combination, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 161–180.
Moon, T. E., Rodney, S., Peng, Y-M., Alberts, D. S., and Meyskens, F. L., Jr., 1986b, Design and compliance considerations of dietary intervention trials, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 267–282.
Morishige, F., Nakamura, T., Nakamura, N., and Morishige, N., 1986, The role of vitamin C in tumor therapy (human), in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 399–427.
Morris, H. P., 1941, Effect of pantothenic acid on growth of the spontaneous mammary carcinoma in female C3H mice, J. Natl. Cancer Inst. 2: 47–54.
Morris, H. P., 1947, Effects on the genesis and growth of tumors associated with vitamin intake, Ann. NY Acad. Sci. 49: 119–140.
Munoz, N., Wahrendorf, J., Bang, L. J., Crespi, M., Thurnham, D. I., Day, N. E., Ji, Z. H., Grassii, A., Yan, L. W., Lin, L. G., Quan, L. Y., Yun, Z. C., Fang, Z. S., Yao, L. J., Correa, P., O’Conor, G. T., and Bosch, X., 1985, No effect of riboflavine, retinol, and zinc on prevalence of precancerous lesions of oesophagus, Lancet 2: 111–114.
Munoz, N., Hayashi, M., Bang, L. J., Wahrendorf, J., Crespi, M., and Bosch, F. X., 1988, Effect of riboflavin, retinol, and zinc on micronuclei of buccal mucosa and of esophagus: A randomized double-blind intervention study in China, J. Natl. Cancer Inst. 79: 687–691.
Murer-Orlando, M. L., and Peterson, A. C., 1985, In situ nick translation of human and mouse chromosomes detected with a biotinylated nucleotide, Exp. Cell Res. 157: 322–334.
Myers, C., McGuire, W., and Young, R., 1976, Adriamycin amelioration of toxicity by alpha tocopherol, Cancer Treat. Rep. 60: 961–962.
Narisawa, T., Reddy, B., Wong, Q., and Weisburger, J., 1976, Effect of vitamin A deficiency on rat colon carcinogenesis, Cancer Res. 36: 1379–1383.
National Research Council, 1989, Diet and Health. Implications for reducing chronic disease risk, Committee on Diet and Health, Food and Nutrition Board, Commission on Life Sciences, National Research Council, National Academy Press, Washington D.C.
Nduka, N., Skidmore, C. J., and Shall, S., 1980, The enhancement of cytotoxicity of N-methyl-N-nitrosourea and of gamma-radiation by inhibitors of poly(ADP-ribose) polymerase, Eur. J. Biochem. 105: 525–530.
Nettlesheim, P., 1980, Inhibition of carcinogenesis by retinoids, Can. Med. Assoc. J. 122: 757–765.
Nettlesheim, P., and Williams, M., 1976, The influence of vitamin A on the susceptibility of rat lung to 3methylcholanthrene, Int. J. Cancer 17: 351–357.
Newberne, P. M., 1986, Lipotropic factors and oncogenesis, Adv. Exp. Med. Biol. 206: 223–251.
Newberne, P., and Rogers, A., 1973, Rat colon carcinogenesis associated with aflatoxin and marginal vitamin A, J. Natl. Cancer Inst. 50: 439–448.
Newberne, P. M., and Rogers, A. E., 1986, Labile methyl groups and the promotion of cancer, Annu. Rev. Nutr. 6: 407–432.
Newberne, P. M., and Suphakam, V., 1984, Influence of the antioxidants vitamins C and E and of selenium on cancer, in: Vitamins, Nutrition, and Cancer ( K. N. Prasad, ed.), Karger, Basel, pp. 46–67.
Nexo, E., Olesen, H., Norredam, K., and Schwartz, M., 1975, A rare case of megaloblastic anaemia caused by disturbances in the plasma cobalamin binding proteins in a patient with hepatocellular carcinoma, Scand. J. Haematol. 14: 320–327.
Nichol, C. A., Smith, G. K., and Duch, D. S., 1985, Biosynthesis and metabolism of tetrahydrobiopterin and molybdopterin, Annu. Rev. Biochem. 54: 729–764.
Nomura, A., Stemmermann, G., Heilbrun, L., Salkeld, R., and Vuillemier, J., 1985, Serum vitamin levels and the risk of cancer of specific sites in men of Japanese ancestry in Hawaii, Cancer Res. 45: 2369–2372.
Nutrition Policy Board, Department of Health and Human Services, 1988, The Surgeon General’s Report on Nutrition and Health, U.S. Department of Health and Human Services, U.S. Government Printing Office, Washington, DC, ( DHHA(PHS) Publication No. 88–50210.
Nutter, L. M., Meisler, N. T., and Thanassi, J. W., 1983, Absence of pyridoxine-(pyridoxamine-) 5’-phosphate oxidase in Morris hepatoma 7777, Biochemistry 22: 1599–1604.
O’Connor, H. J., Habibzedah, N., Schorah, C. J., Axon, A. T., Riley, S. E., and Garner, R. C., 1985, Effect of increased intake of vitamin C on the mutagenic activity of gastric juice and intragastric concentrations of ascorbic acid, Carcinogenesis 6: 1675–1676.
Odukoya, O., Hawach, F., and Shklar, G., 1984, Retardation of experimental oral cancer by topical vitamin E, Nutr. Cancer 6: 98–104.
Ohno, Y., Yoshida, O., Oishi, K., Okada, K., Yamabe, H., and Schroeder, F. H., 1988, Dietary beta-carotene and cancer of the prostate: A case-control study in Kyoto, Japan, Cancer Res. 48: 1331–1336.
Olson, J. A., 1987, Recommended dietary intakes (RDI) of vitamin A in humans, Am. J. Clin. Nutr. 45: 704–716.
Olson, J. A., and Hodges, R. E., 1987, Recommended dietary intakes (RDI) of vitamin C in humans, Am. J. Clin. Nutr. 45: 693–703.
Ong, D., and Chytil, F., 1983, Vitamin A and cancer, Vit. Horm. 40: 105–44.
Pacernick, L. J., Soltani, K., and Lorincz, A. L., 1975, The inefficacy of riboflavin against ultraviolet-induced carcinogenesis, J. Invest. Dermat. 65: 547–548.
Paganini-Hill, A., Chao, A., Ross, R. K., and Henderson, B. E., 1987, Vitamin A, beta-carotene, and the risk of cancer: A prospective study, J. Natl. Cancer Inst. 79: 443–448.
Park, C. H., 1985, Biological nature of the effect of ascorbic acids on the growth of human leukemic cells, Cancer Res. 45: 3969–3973.
Pascoe, G. A., Olafsdottir, K., and Reed, D. J., 1987, Vitamin E protection against chemical-induced cell injury. I. Maintenance of cellular protein thiols as a cytoprotective mechanism. Arch. Biochem. Biophys. 256: 150–158.
Pastorino, U., Pisani, P., Berrino, F., Andreoli, C., Barbieri, A., Costa, A., Mazzoleni, C., Gramegna, G., and Marubini, E., 1987, Vitamin A and female lung cancer: A case—control study in plasma and diet, Nutr. Cancer 10: 171–179.
Patek, P., Collins, J., Yogeeswaran, G., and Dennert, G., 1979, Antitumor potential of retinoic acid, Int. J. Cancer 24: 624–628.
Pauling, L., and Moertel, C., 1986, A proposition: Megadoses of vitamin C are valuable in the treatment of cancer, Nutr. Rev. 44: 28–32.
Pauling, L., Willoughby, R., Reynolds, R., Blaisdell, B., and Lawson, S., 1982, Incidence of squamous cell carcinoma in hairless mice irradiated with ultraviolet light in relation to intake of ascorbin acid (vitamin C) and of D,L-alpha-tocopheryl acetate (vitamin E), Int. Z. vitam. Ernahrungsforsch. 23: 53–82.
Pauling, L., Nixon, J. C., Stitt, F., Marcuson, R., Dunham, W. B., Barth, R., Bensch, K., Herman, Z. S., Blaisdell, B. E., Tsao, C., Prender, M., Andrews, V., Willoughby, R., and Zuckerkandl, E., 1985, Effect of dietary ascorbic acid on the incidence of spontaneous mammary tumors in RIII mice, Proc. Natl. Acad. Sci. USA 82: 5185–5189.
Paveic, Z., Dave, S., Bialkowski, S., Priore, R., and Greco, W., 1980, Antitumor activity of Cornynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma, Cancer Res. 40: 4617–4621.
Peck, G., Olsen, T., Butkus, J., Pandya, M., Arnaud-Battandier, J., Yoder, F., and Lewis, W., 1979, Treatment of basal cell carcinomas with 13-cis-retinoic acid, Proc. Am. Assoc. Clin. Res. 20: 56.
Pelej, I., Heyden, S., Knowles, M., and Hames, O., 1984, Serum retinol and risk of subsequent cancer; extension of the Evans Country, Georgia, study, J. Natl. Cancer Inst. 73: 1455–1488.
Percheliet, J. P., Abney, N. L., Thomas, R. M., Guislain, Y. L., and Perchellet, E. M., 1987, Effects of combined treatments with selenium, glutathione, and vitamin E on glutathione peroxidase activity, ornithine decarboxylase induction, and complete and multistage carcinogenesis in mouse skin, Cancer Res. 47: 477–485.
Pierson, H. F., Fisher, J. M., and Rabinovitz, M., 1985, Depletion of extracellular cysteine with hydroxocobalamin and ascorbate in experimental murine cancer chemotherapy, Cancer Res. 45: 4727–4731.
Pinto, J., Huang, Y. P., Chaudhuri, R., and Rivlin, R. S., 1975, Riboflavin excretion and turnover in an unusual case of multiple myeloma, Clin. Res. 23: 426A.
Polliack, A., and Sasson, Z., 1972, Enhancing effect of excess topical vitamin A on Rous sarcomas in chickens, J. Nad. Cancer Inst. 48: 407–416.
Pologe, L. G., Goyal, A., and Greer, J., 1982, Nature of the riboflavin interaction with the immunoglobulin IgGgar: Analogue binding studies, Mol. Immunol. 19: 1499–1507.
Popov, A. I., 1987, Effect of the nonspecific prevention of thrombogenic complications on late results in the combined treatment of bladder cancer, Med. Radio!. (Mosk.) 32: 42–45.
Potera, C., Rose, D. P., and Brown, R. R., 1977, Vitamin B6 deficiency in cancer patients, Am. J. Clin. Nutr. 30: 1677–1679.
Potter, J. D., and McMichael, A. J., 1986, Diet and cancer of the colon and rectum: A case—control study, J. Natl. Cancer Inst. 76: 557–569.
Prasad, K. N., 1984, Vitamins, Nutrition, and Cancer, Karger, Basel.
Prasad, K. N., 1988, Mechanisms of action of vitamin E on mammalian tumor cells in culture, Prog. Clin. Biol. Res. 259: 363–375.
Presant, C., and Bearman, R., 1981, Randomized study of 13-cis-retinoic acid plus buslufan (B) or B alone in chronic phase chronic granulocytic leukemia, Proc. Am. Soc. Clin. Oncol. 22: 448.
Prior, F. G. R., 1985, Theoretical involvement of vitamin B6 in tumour initiation, Med. Hypotheses 16: 421–428.
Rachmilewitz, B., Rachmilewitz, M., Moshkowitz, B., and Gross, J. 1971, Serum transcobalamin in myeloid leukemia, J. Lab. Clin. Med. 78: 275–288.
Rakieten, N., Gordon, B. S., Beaty, A., Cooney, D. A., Davis, R. D., and Schein, P. S., 1971, Pancreatic islet tumors produced by the combined action of streptozotocin and nicotinamide, Proc. Soc. Exp. Biol. Med. 137: 280–283.
Rama, B., and Prasad, K., 1983, Study on the specificity of alpha-tocopherol (vitamin E) acid succinate effects on melanoma, glioma, and neuroblastoma cells in culture, Proc. Soc. Exp. Biol. Med. 174: 302–307.
Rama Rao, P. B., Lagerlof, B., Einhorn, J., and Reizenstein, P. G., 1965, Folic acid activity in leukemia and cancer, Cancer Res. 23: 221–224.
Rao, J. McBride, T., and Oleson, J., 1968, Recognition and evaluation of iapachol as an antitumor agent, Cancer Res. 28:1952–1954.
Reynolds, R. D., 1986 Vitamin B6 deficiency and carcinogenesis, Adv. Exp. Med. Biol. 206: 339–347.
Rivlin, R. S., 1975, Riboflavin and cancer, in: Riboflavin ( R. S. Rivlin, ed.), Plenum Press, New York, pp. 369–391.
Roberts, A., and Sporn, M., 1984, Cellular biology and biochemistry of the retinoids, in: The Retinoids, vol. 2 ( M. Sporn, A. Roberts, and D. Goodman, eds.), Academic Press, New York, pp. 209–286.
Robson, L. C., and Schwarz, M. R., 1980, The effects of vitamin B6 deficiency on the lymphoid system and immune responses, in: Vitamin B6 Metabolism and Role in Growth ( G. P. Tryfiates, ed.), Food and Nutrition Press, Westport, CT, pp. 205–222.
Rogers, A. E., 1975, Variable effects of a lipotrope-deficient, high-fat diet on chemical carcinogenesis in rats, Cancer Res. 35: 2469–2474.
Rogers, A., Herndon, B., and Newberne, P., 1973, Induction by dimethylhydrazine of intestinal carcinoma in normal rats and rats fed high or low levels of vitamin A, Cancer Res. 33: 1003–1009.
Rokos, H., Rokos, K., Frisius, H., and Kirstaeder, H. J., 1980, Altered urinary excretion of pteridines in neoplastic disease. Determination of biopterin, neopterin, xanthipterin, and pterin, Clin. Chim. Acta 105: 275–286.
Rose, D. P., and Sheff, M. D., 1967, Tryptophan metabolism in carcinoma of the breast, Lancet 1: 239–241.
Rosen, F., Mihich, E., and Nichol, E. E., 1964a, Selective metabolic and chemotherapeutic effects of vitamin B6 adntimetabolites, Vit. Horm. 22: 609–641.
Rosen, F., Satobayashi, H., and Nichol, C. A., 1964b, Different effects of folic acid deficiency and treatment with amethopterin on the growth of several rat tumors, Proc. Am. Assoc. Cancer Res. 5: 54.
Rosenberg, M. R., Novicki, D. L., Jirtle, R. L., Novotny, A., and Michalopoulos, G., 1985, Promoting effect of nicotinamide on the development of renal tubular cell tumors in rats initiated with diethylnitrosamine, Cancer Res. 45: 809–814.
Rosenberg, M. R., Strom, S. C., Pachman, S., Slotkin, T. A., and Michalopoulos, G., 1986, Induction of rat kidney ornithine decarboxylase by nicotinamide without a concomitant increase in DNA synthesis, Carcinogenesis 7: 175–178.
Rostock, R., Stryker, J., and Abt, A., 1980, Evaluation of high dose vitamin E as a radioprotective agent, Radiology 136: 763–766.
Ruddell, W. S. J., Bone, E. S., Hill, M. J., and Waters, C. L., 1978, Pathogenesis of gastric cancer in pernicious anemia, Lancet 1: 521–523.
Russell, M. J., Thomas, B. S., and Bulbrook, R. D., 1988, A prospective study of the relationship between serum vitamins A and E and risk of breast cancer, Br. J. Cancer 57: 213–215.
Saccomanno, G., Moran, P., Schmiidy, R., Hartshorn, D., Brian, D., Dreher, W., and Sowada, B., 1982, Effects of 13-cis-retiinoids on premalignant and malignant cells of lung origin, Acta Cytol. 26: 78–84.
Saffiotti, U., Montesano, R., Sellakumar, A., and Borg, S., 1967, Experimental cancer of the lung, Cancer 20: 857–864.
Salonen, J., Salonen, R., Lappetelainen, R., Maenpaa, P., Alfthan, G., and Puska, P., 1985, Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: Matched case—control analysis of prospective data, Br. Med. J. 290: 417–420.
Samuels, L. L., Moccio, D. M., and Sirotnak, F. M., 1985, Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro, Cancer Res. 45: 1488–1485.
Samuels, L. L., Goutas, L. J., Priest, D. G., Piper, J. R., and Sirotnak, F. M., 1986, Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse, Cancer Res. 46: 2230–2235.
Sato, T., Takusagawa, K, and Konno, K., 1984, Effect of 1 alpha-hydroxyvitamin D3 on metastasis of rat ascites hepatoma K-231, Br. J. Cancer 50: 123–125.
Schein, P. S., 1969, 1-Methyl-l-nitrosourea and dialkylnitrosamine depression of nicotinamide adenine dinucleotide, Cancer Res. 29: 1226–1232.
Schmaehl, D., and Habs, M., 1978, Experiments on the influence of an aromatic retinoid on the chemical carcinogenesis in rats by butyl-butanol-nitrosamine and 1,2-dimethylhydrazine, Arzneim. Forsch. 28: 49–51.
Schmitt-Graff, A., and Scheulen, M. E., 1986, Prevention of adriamycin cardiotoxicity by niacin, isocitrate or N-acetyl-cysteine in mice. A morphological study, Pathol. Res. Pract. 181: 168–174.
Schober, S. E., Comstock, G. W., Helsing, K. J., Salkeld, R. M., Morris, J. S., Rider, A. A., and Brookmeyer, R., 1987, Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk, Am. J. Epidemiol. 126: 1033–1041.
Schrijver, J., Alexieva-Figusch, J., van Breederode, N., and van Gilse, H. A., 1987, Investigations on the nutritional status of advanced breast cancer patients. The influence of long-term treatment with megestrol acetate or tamoxifen, Nutr. Cancer 10: 231–245.
Schroder, E., and Black, P., 1980, Retinoids: Tumor preventors or tumor enhancers? J. Natl. Cancer Inst. 65: 671–674.
Sestili, M. A., 1983, Possible adverse health effects of vitamin C and ascorbic acid, Semin. Oncol. 10: 299–304.
Shamberger, R. J., Nutrition and Cancer, Plenum Press, New York, 1984, Chapter 4.
Shamberger, R., Beaman, K., Corlett, C., and Kasten, B., 1978, Effect of selenium and other antioxidants on the mutagenicity of malonaldehyde, Fed. Proc. 37: 261.
Shane, B., and Stokstad, E. L. R., 1985, Vitamin B12-folate interrelationships, Annu. Rev. Nutr. 5: 115–141.
Shapiro, D. M., Dietrich, L. S., and Shies, M. D., 1957, Quantitative biochemical differences between tumor and host as a basis of chemotherapy, Cancer Res. 17: 600–604.
Shekelle, R., Lepper, M., Liu, S., Maliza, C., Raynor, W., Rossof, A., Paul, O., Shylock, A., and Stamler, J., 1981, Dietary vitamin A and risk of cancer in the Western Electric study, Lancet 2: 1186–90.
Sheppard, K., Danbury, D. A., Davies, J. M., and Ryrie, D. R., 1984, Cobalamin and folate binding proteins in
human tumour tissue, J. Clin. Pathol. 37:1336–1338.
Shinozuka, H., and Lombardi, B., 1980, Synergistic effect of a choline-devoid diet and pheonbarbital in promoting the emergence of foci of gamma-glutamyltranspeptidase-positive hepatocytes in the liver of carcinogen-treated rats, Cancer Res. 40: 3846–3849.
Shirai, T., Ikawa, E., Hirose, M., Thamavit, W., and Ito, N., 1985a, Modification by five antioxidants of 1,2dimethylhydrazine-initiated colon carcinogenesis in F344 rats, Carcinogenesis 6: 637–639.
Shirai, T., Masuda, A., Fukushima, S., Hosoda, K., and Ito, N., 1985b, Effects of i_ ascorbate and related compounds on rat stomach carcinogenesis initiated by N-methyl-N’-nitro-N-nitroguanidine, Cancer Lett. 29: 283–288.
Shivapurkar, N., and Poirier, L. A., 1983, Tissue levels of S-adenosylmethionine and S-adenosylhornocysteine in rats fed methyl-deficient, amino acid-defined diets for one to five weeks, Carcinogenesis 4: 1051–1057.
Shklar, G., 1982, Oral mucosal carcinogenesis in hamsters: Inhibition by vitamin E, J. Natl. Cancer Inst. 68: 791–797.
Shklar, G., Flynn, E., Szbo, G., and Marefat, P., 1980, Retinoid inhibition of experimental ligua) carcinogenesis, J. Natl. Cancer Inst. 65: 1307–1316.
Shklar, G., Schwartz, J., Trickier, D. P., and Niukian, K., 1987, Regression by vitamin E of experimental oral cancer, J. Natl. Cancer Inst. 78: 987–992.
Shoentel, R., 1977, The role of nicotinamide and other modifying factors in diethylnitrosamine carcinogenesis, Cancer 40: 1833–1840.
Sherman, M. L (ed.), 1986, Retinoids and Cell Differentiation, CRC Press, Boca Raton, FL.
Siegel, B. V., and Morton, J. I., 1984, Vitamin C and immunity: Influence of ascorbate on prostaglandin Ez synthesis and implications for natural killer cell activity, lnt. J. Vit. Nutr. Res. 54: 339–342.
Silverman, J., Katayama, S., Zelenkas, K., Lauber, J., Musser, T., Reddy, M., Levenstein, M.. and Weisburger, J., 1981, Effect of retinoids on the induction of colon cancer in F344 rats by N-methyl-N-nitrosurea or by 1,2 dimethylhydrazine, Carcinogenesis 2: 1167–1172.
Slaga, T., and Bracken, W., 1977, The effects of antioxidants on skin tumor initiation and aryl hydrocarbon hydroxlase, Cancer Res. 37: 1631–1635.
Smith, D., Rogers, A., Herndon, B., and Nebeme, P., 1975a, Vitamin A and benzo(a)pyrene-induced respiratory tract carcinogenesis in hamsters fed a commercial diet, Cancer Res. 35: 11–16.
Smith, D., Rogers, A., and Newbeme, P., 1975b, Vitamin A and benzo(a)pyrene carcinogenesis in the respiratory tract of hamsters fed a semisynthetic diet, Cancer Res. 35: 1485–1487.
Sonneveld, P., 1978, Effect of alpha tocopherol on the cardiotoxicity of Adriamycin in the rat, Cancer Treat. Rep. 62: 1033–36.
Sporn, M., and Newton, D., 1979, Chemoprevention of cancer with retinoids, Fed. Proc. 38: 2528–2534.
Stahelin, H., Buess, E., Rosel, F., Widmer, L., and Brubacher, G., 1982, Vitamin A, cardiovascular risks, and mortality, Lancet 1: 394–395.
Stahelin, H. B., Rosel, F., Buess, E., and Brubacher, G., 1984, Cancer, vitamins, and plasma lipids: Prospective Basel study, J. Natl. Cancer Inst. 73: 1463–1468.
Stahl, R. L., Farber, C. M., Liebes, L. F., and Silber, R., 1985, Relationship of dehydroascorbic acid transport to cell lineage in lymphocytes from normal subjects and patients with chronic lymphocytic leukemia, Cancer Res. 45: 6507–6512.
Stam, J., Germano, G., and Boorsma, M., 1982, Preliminary results of a 3 year double-blind study of the aromatic retinoid Tigason versus placebo as adjuvant therapy in patients who underwent a curative resection for epidermoid carcinoma of the lung, Eur. J. Respir. Dis. 63(Suppl. 125):Abstr. 100.
Stea, B., Halpern, R. M., Halpern, B. C., and Smith, R. A., 1981, Urinary excretion of unconjugated pterins in cancer patients and normal individuals, Clin. Chim. Acta 113: 231–242.
Steen, P. H., Wallace, C. D., and Hoffman, R. M., 1984, Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines, J. Cell. Physiol. 119: 29–34.
Stehr, P., 1983, Vitamin A deficiencies as a predisposing factor in the development of stomach cancer, Diss. Abstr. Int. 43:2863-B.
Stern, P. H., Wallace, C. D., and Hoffman, R. M., 1984, Altered methionine metabolism occurs in all members of a set of diverse human tumor cell lines, J. Cell. Physiol. 119: 29–34.
Stewart, D., Speer, R., Ridgeway, H., and Hill, J., 1979, Combination chemotherapy of leukemia L1210 with platinum compounds and vitamins, J. Clin. Hematol. Oncol. 9: 235–239.
Stitch, H., Rosin, M., and Vallejera, M., 1984, Effect of vitamin A and Beta-carotene administration on the frequencies of micronucleated buccal mucosa cells of betel nut and tobacco chewers, Proc. Am. Assoc. Cancer Res. 25: 125.
Su, Y. Z., Duarte, T. E., Dill, P. L., and Weisenthal, L. M., 1987, Selective enhancement by menadiol of in vitro drug activity in human lymphatic neoplasms, Cancer Treat. Rep. 71: 619–625.
Surwit, E., Graham, V., Doregemueller, W., Alberts, D., Chvapil, M., Don, R., Davis, J., and Meyskens, Jr., F., 1982, Evaluation of topically applied trans-retinoic acid in the treatment of cervical intrepithelial lesions, Am. J. Obstet. Gynecol. 143: 821–823.
Svingen, B., Powis, G., Appel, P., and Scott, M., 1981, Protection by alpha-tocopherol and dimethylsulfoxide (DMSO) against Adriamycin induced skin ulcers in the rat, Cancer Res. 41: 3395–3399.
Taheri, M. R., Wickremasinghe, R. G., Jackson, B. F., and Hoffbrand, A. V., 1982, Effect of folate analogues and vitamin Bt2 on provision of thymine nucleotides for DNA synthesis in megaloblastic anemia, Blood 59: 634–640.
Taper, H. S., de Gerlache, J., Lans, M., and Roberfroid, M., 1987, Non-toxic potentiation of cancer chemotherapy by combined C and K3 vitamin pre-treatment, Int. J. Cancer 40: 575–579.
Tekenaga, K., Honma, Y., and Hozumi, M., 1981, Inhibition of differentiation of mouse myeloid leukemia cells by phenolic antioxidants and alpha-tocopherol, GANN 72: 104–112.
Temcharoen, P., Anukarahanonta, T., and Bhamarapravati, N., 1978, Influence of dietary protein and vitamin B12 on the toxicity and carcinogenicity of aflatoxins in rat liver, Cancer Res. 38: 2185–2190.
Teppo, L., and Saxén, E., 1979, Epidemiology of colon cancer in Scandinavia, Isr. J. Med. Sci. 15: 322–328.
Thanassi, J. W., Nutter, L. M., Meisler, N. T., Commers, P., and Chiu, J-F., 1981, Vitamin B6 metabolism by Morris hepatomas, J. Biol. Chem. 256: 3370–3375.
Thanassi, J. W., Meisler, N. T., and Kittler, J. M., 1985, Vitamin B6 metabolism and cancer, in: Vitamin B6: Its Role in Health and Disease ( J. E. Leklem, R. D. Reynolds, and E. E. McCoy, eds.), Alan R. Liss, New York, pp. 319–336.
Thatcher, N., Blackledge, G., and Crowther, D., 1980, Advanced recurrent squamous cell carcinoma of the head and neck, Cancer 46: 1324–1328.
Thurnham, D. I., Rathakette, P., Hambridge, K. M., Munoz, N., and Crespi, M., 1982, Riboflavin, vitamin A and zinc status in Chinese subjects in a high-risk area for oesophageal cancer in China, Hum. Nutr. Clin. Nutr. 36C: 337–349.
Toth, B., and Patil, K., 1983, Enhancing effect of vitamin E on murine intestinal tumorigenesis by 1,2dimethylhydrazine dihydrochloride, J. Natl. Cancer Inst. 70: 1107–1111.
Trickier, D., and Shklar, G., 1987, Prevention by vitamin E of experimental oral carcinogenesis, J. Natl. Cancer Inst. 78: 165–169.
Troll, W., Wiesner, R., and Frenkel, K., 1987, Anticarcinogenic action of protease inhibitors, Adv. Cancer Res. 49: 265–283.
Trown, P., Byck, M., and Hansen, R., 1976, Inhibition of growth and regression of a transplantable rat chrondrosarcoma by three retinoids, Cancer Treat. Rep. 60: 1647–1653.
Tryfiates, G. P., and Morris, H. P., 1974, The effect of pyridoxine deficiency on tyrosine transaminase activity and growth of four mouse hepatomas, J. Natl. Cancer Inst. 52: 1259–1262.
Tryfiates, G. P., Bishop, R., and Smith, R. R., 1983, Identification of fatty acids associated with a novel tumor vitamin metabolite by GC-mass spectroscopy, J. Nutr. Growth Cancer 1: 1–9.
Ura, H., Denda, A., Yokose, Y., Tsutsumi, M., and Konishi, Y., 1987, Effect of vitamin E on the induction and evolution of enzyme altered foci in the liver of rats treated with diethylnitrosamine, Carcinogenesis 8: 1595–1600.
van Eys, J., 1985, Nutrition and cancer, Annu. Rev. Nutr. 5: 435–461.
van Helden, P. D., Beyers, A. D., Bester, A. J., and Jaskiewicz, K., 1987, Esophageal cancer: Vitamin and lipotrope deficiencies in an at-risk South African population, Nutr. Cancer 10: 247–255.
Van Maanen, J. M., de Ruiter, C., de Vries, J., Koostra, P. R., Gobas, F., and Pinedo, H. M., 1985, The role of metabolic activation by cytochrome P-450 in covalent binding of VP 16–213 to rat liver and He La cell microsomal proteins, Eur. J. Cancer Clin. Oncol. 21: 1099–1106.
van Rensburg, S. J., 1981, Epidemiological and dietary evidence for a specific nutritional predisposition to esophageal cancer, J. Natl. Cancer Inst. 67: 243–251.
van Tonder, S., Kew, M. C., Hodkinson, J., Metz, J., and Fernandez-Costa, F., 1985, Serum vitamin BI2 binders in South African blacks with hepatocellular carcinoma, Cancer 56: 789–792.
Van Vleet, V., and Ferrans, V., 1980, Evaluation of vitamin E and selenium protection against chronic adriamycin toxicity in rabbits, Cancer Treat. Rep. 64: 315–317.
Wade, A. E., Greene, F. E., Ciordia, R. H., Meadows, J. S., and Caster, W. 0., 1969, Effect of dietary thiamin intake on hepatic drug metabolism in the rat, Biochem. Pharmacol. 18: 2288–2292.
Wade, A. E., Wu, B. C., Holbrooke, C. M., and Caster, W. 0., 1973, Effects of thiamin antagonists on drug hydroxylation and properties of cytochrome P-450 in the rat, Biochem. Pharm. 22: 1573–1580.
Wagner, C., 1985, Folate-binding proteins, Nutr. Rev. 43: 293–299.
Wagner, C., Briggs, W. T., and Cook, R. J., 1985a, Inhibition of glycine N-methyltransferase activity by folate derivatives: Implications for regulation of methyl group metabolism, Biochem. Biophys. Res. Commun. 127: 746–752.
Wagner, D., Shuker, D. E. G., Blimazes, C., Obiedzinski, M., Baker, I., Young, V. R., and Tannenbaum, S. R., 1985b, Effects of vitamins C and E on endogenous synthesis of N-nitrosamino acids in humans: Presursor-product studies with [15N]nitrate, Cancer Res. 45: 6519–6522.
Wald, N., Idle, M., and Boreham, J., 1980, Low serum vitamin A and subsequent risk of cancer, Lancet 2: 813–815.
Wald, N., Boreham, J., Hayward, J., and Bulbrook, R., 1984, Plasma retinol, beta-carotene, and vitamin E levels in relation to the future risk of breast cancer, Br. J. Cancer 49: 321–324.
Wahrendorf, J., Munoz, N., Lu, J. B., Thurnham, D. I., Crespi, M., and Bosch, F. X., 1988, Blood, retinol and zinc riboflavin status in relation to precancerous lesions of the esophagus: Findings from a vitamin intervention trial in the People’s Republic of China, Cancer Res. 48: 2280–2283.
Wang, Y., Madanat, F., and Kimball, J., 1980, Effect of vitamin E against Adriamycin-induced toxicity in rabbits, Cancer Res. 40: 1022–1027.
Wang, T., Miller, K. W., Tu, Y. Y., and Yang, C. S., 1985, Effects of riboflavin deficiency on metabolism of nitrosamines by rat liver microsomes, J. Natl. Cancer Inst. 74: 1291–1297.
Ward, J., Sporn, M., Wenk, M., Smith, J., Feeser, D., and Dean, R., 1978, Dose response to intrarectal administration of N-methyl-N-Nitrosurea and histopatologic evaluation of the effect of two retinoids on colon lesions induced in rats, J. Natl. Cancer Inst. 60: 1489–1493.
Wargovich, M. J., and Lointier, P. H., 1987, Calcium and vitamin D modulate mouse colon epithelial proliferation and growth characteristics of a human colon tumor cell line, Can. J. Physiol. Pharmacol. 65: 472–477.
Warrell, R., Coonley, C., and Itri, L., 1982, Clinical effects of 13-cis-retinoic acid in patients with lymphoid cancer, Clin. Res. 30: 692A.
Warwick, G. P., and Harrington, J. S., 1973, Some aspects of the epidemiology and etiology of esophageal cancer with particular emphasis on Transkei, South Africa, Adv. Cancer Res. 17: 81–229.
Wassertheil-Smoller, S., Romney, S. L., Wylie-Rosett, J., Slagle, G., Miller, D., Lucido, C., Duttagupta, P., and Palan, R., 1981, Dietary vitamin C and uterine cervical dysplasia, Am. J. Epiderm. 114: 714–724.
Watson, R. R., 1986, Retinoids and vitamin E: Modulators of immune functions and cancer resistance, in: Vitamins and Cancer ( F. L. Meyskens, Jr., and K. N. Prasad, eds.), Humana Press, Clifton, NJ, pp. 439–451.
Wattenberg, L., 1972, Inhibition of carcinogenic and toxic effects of polycyclic hydroxcarbons by phenolic antioxidants and ethoxyquin, J. Natl. Cancer Inst. 48: 1425–1430.
Waxman, S., and Bruckner, H., 1982, The enhancement of 5-fluorouracil antimetabolic activity by leucovorin, menadione, and alpha-tocopherol, Eur. J. Can. Clin. Oncol. 18: 685–692.
Waxman, S., and Gilbert, H. S., 1973, A tumor-related vitamin B12-binding protein in adolescent hepatoma, N. Engl. J. Med. 289: 1053–1056.
Weber, T., Seitz, R. J., Liebert, U. G., Gallasch, E., and Wechsler, W., 1985, Affinity cytochemistry of vascular endothelia in brain tumors by biotinylated Ulex europaeus type I lectin (UEA I), Acta Neuropathol. 67: 128–135.
Welsch, C., Goodrich-Smith, M., Brown, C., and Crowe, N., 1981, Enhancement by retinyl acetate of hormone-induced mammary tumorigenesis in female GR/A mice, J. Natl. Cancer Inst. 67: 935–938.
Wenk, M., Ward, J., Resnik, G., and Dean, J., 1981, Effects of three retinoids on colon adenocarcinomas, sarcomas, and hyperplastic polyps induced by intrarectal N-methyl-N-nitrosurea administration in male F344 rats, Carcinogenesis 2: 1161–1166.
Werner, B., Hrynyschyn, K., and Schafer, H., 1985, Long-term study on vitamin C: No effect on experimental carcinogenesis, Langenbecks Arch. Chir. 363: 185–193.
Whelen, W., Walker, B., and Kelleher, J., 1983, Zinc, vitamin A and prostate cancer, Br. J. Urol. 55: 525–528.
White, H. B., III, and Merrill, A. H., Jr., 1988, Riboflavin-binding proteins, Annu. Rev. Nutr. 8: 279–299.
Whittaker, J., and Al-Ismail, S., 1983, Effect of digoxin and vitamin E in preventing cardiac damage caused by doxorubicin in acute myeloid leukemia, Br. J. Med. 288: 283–284.
Willett, W. C., 1986, Selenium, vitamin E, fiber, and the incidence of human cancer: An epidemiologic perspective, Adv. Exp. Med. Biol. 206: 27–34.
Willett, W., Polk, B., Underwood, B., Stampfer, M., Pressel, S., Rosner, B., Taylor, J., Schneider, K., and Hames, C., 1984, Relation of serum vitamins A and E and carotenoids to the risk of cancer, N. Engl. J. Med. 310: 430–434.
Wittes, R. E., 1985, Vitamin C and cancer, N. Engl. J. Med. 312: 178–179.
Wolbach, S., and Howe, P., 1925, Tissue changes following deprivation of fat-soluble A vitamin, J. Exp. Med. 42: 753–777.
Woolley, P. V., Kumar, S., Fitzgerald, P., and Simpson, R. T., 1987, Ascorbate potentiates DNA damage by 1- methyl-nitrosourea in vivo and generates DNA strand breaks in vitro, Carcinogenesis 8: 1657–1662.
Wynder, E. L., Hultberg, S., Jacobson, F., and Bross, I. J., 1957, Environmental factors in cancer of the upper alimentary tract. A Swedish study with special reference to Plummer—Vinson (Patterson—Kelly) syndrome, Cancer 10: 470–479.
Yamamoto, R. S., 1980, Effect of vitamin B12-deficiency in colon carcinogenesis, Proc. Soc. Exp. Biol. Med. 163: 350–353.
You, W. C., Blot, W. J., Chang, Y. S., Ershow, A. G., Yang, Z. T., An, Q., Henderson, B., Xu, G. W., Fraumeni, J. F., Jr., and Wang, T. G., 1988, Diet and high risk of stomach cancer in Shandong, China, Cancer Res. 48:3518–3523.
Young, V. R., and Newberne, P. M., 1981, Vitamins and cancer prevention: Issues and dilemmas, Cancer 47 (Suppl. 5): 1226–1240.
Ziegler, I., Fink, M., and Wimanns, W., 1982, Biopterin levels in peripheral blood cells as a marker for hematopoietic cell proliferation during leukemia and polycythemia vera, Blut 44: 231–240.
Ziegler, R. G., 1986, Epidemiologic studies of vitamins and cancer of the lung, esophagus, and cervix, Adv. Exp. Med. Biol. 206: 11–26.
Ziegler, R., Mason, T., Stemhagen, A., Hoover, R., Schoenberg, J., Gridley, G., Virgo, P., Altamn, R., and Fraumeni, J., Jr., 1984, Dietary carotene and vitamin A and risk of lung cancer among white men in New Jersey, J. Natl. Cancer Inst. 73: 1429–35.
Ziegler, R. G., Mason, T. J., Sternhagen, A., Hoover, R., Schoenberg, J. B., Gridley, G., Virgo, P. W., and Fraumeni, J. F., Jr., 1986, Carotenoid intake, vegetables, and the risk of lung cancer among white men in New Jersey, Am. J. Epidemiol. 123: 1080–1093.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer Science+Business Media New York
About this chapter
Cite this chapter
Merrill, A.H., Foltz, A.T., McCormick, D.B. (1991). Vitamins and Cancer. In: Alfin-Slater, R.B., Kritchevsky, D. (eds) Cancer and Nutrition. Human Nutrition, vol 7. Springer, Boston, MA. https://doi.org/10.1007/978-1-4757-9561-5_12
Download citation
DOI: https://doi.org/10.1007/978-1-4757-9561-5_12
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4757-9563-9
Online ISBN: 978-1-4757-9561-5
eBook Packages: Springer Book Archive